Get started
Author

Alexis Krolick

Observed name: A. Krolick
Observed institution: PTC Therapeutics (United States)
OpenAlex ID: A5093736070
A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase deficiency patients
2024 · Hui-Min Lee, Saadet Mercimek-Andrews, et al. · Orphanet Journal of Rare Diseases · 5
PDF
Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L‐Amino Acid Decarboxylase Deficiency Using an MR ‐Compatible Cannula: 48 Weeks of Follow‐Up
2026 · Daniel J. Curry, Phillip L. Pearl, et al. · Journal of Inherited Metabolic Disease · 2
Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry
2025 · C. Werner, J. Gruenert, et al. · Neuropediatrics
CO177 Blood Phenylalanine (Phe) Levels in Individuals With Phenylketonuria (PKU): A United States Electronic Health Records (US EHR) and Medical Notes Study
2025 · Nicola Longo, Rongrong Zhang, et al. · Value in Health
Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry (P7-6.008)
2025 · Christian Werner, Eugenio Mercuri, et al. · Neurology
O14: Administration of eladocagene exuparvovec using the SmartFlow magnetic resonance-compatible ventricular cannula in pediatric patients with aromatic ʟ-amino acid decarboxylase deficiency
2025 · Alexis Krolick, Paul Hwu, et al. · Genetics in Medicine Open
PDF
Works count: 6
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type